Using FGF21 supplementation and knockout of FGF21, we evaluated if FGF21 promoted physiological retinal vessel growth through activation of the APN pathway in a mouse model of hyperglycemia-induced vascular growth suppression (a model of the contribution of metabolism to Phase I retinopathy). Here, FGF21 is linked to retinal disorder.